Kenvue Inc. (KVUE)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Kirk L. Perry
|
CEO & Director | 2.94M | -- | 1967 |
|
Mr. Michael P. Wondrasch
|
Chief Technology & Data Officer | 1.02M | -- | 1969 |
|
Mr. Matthew Orlando
|
General Counsel | 1.25M | -- | 1977 |
|
Mr. Carlton Lawson
|
Group President of Europe, Middle East & Africa | 1.41M | -- | 1969 |
|
Ms. Heather R. Howlett
|
Interim CFO & Chief Accounting Officer | -- | -- | 1978 |
|
Ms. Meredith Stevens
|
Chief Operations Officer | 1.83M | -- | 1963 |
|
Dr. Caroline Tillett Ph.D.
|
Chief Scientific Officer | -- | -- | 1972 |
|
Mr. Jonathan Halvorson
|
Chief Digital & Marketing Officer | -- | -- | 1983 |
|
Mr. Anil Agarwal
|
Head of Total Rewards | -- | -- | -- |
|
Mr. Russell Dyer
|
Chief Corporate Affairs Officer | -- | -- | 1981 |
Kenvue Inc.
- Sector:
- Consumer Defensive
- Industry: Household & Personal Products
- Full Time Employees:
- 21,780
Description
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Corporate Governance
Upcoming Events
October 30, 2026 at 12:30 PM UTC
Kenvue Inc. Earnings Date
Recent Events
November 2, 2026 at 12:00 AM UTC
25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured
October 2, 2026 at 12:00 AM UTC
Dividend Date
September 21, 2026 at 12:00 AM UTC
Ex-Dividend Date
May 28, 2026 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
